{"schema_version":"secwatch.filing_event.v1","accession":"0001808220-24-000008","form_type":"8-K","ticker":"GOCO","cik":"0001808220","company_name":"GoHealth, Inc.","filed_at":"2024-03-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.612931+00:00","generated_at":"2026-06-04T21:28:42.977939+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"GoHealth reports FY2023 cash from ops up 79% to $109.1M; Q4 rev $276.7M","bullets":["Q4 2023 net revenue $276.7M vs $69.4M YoY; full-year $734.7M vs $631.7M.","Q4 net loss improved 98.5% to $2.3M; Adjusted EBITDA $57.0M (up 160%).","Full-year net loss of $151.3M improved 59.8%; Adjusted EBITDA $75.1M (up 158%).","Non-agency Medicare revenue reached 60% of total in Q4, up from 26% in 2022.","No Lookback adjustment in 2023; Company assisted over 2M Medicare consumers."],"urls":{"canonical":"https://secwatch.observer/filing/0001808220-24-000008","json":"https://secwatch.observer/filing/0001808220-24-000008.json","markdown":"https://secwatch.observer/filing/0001808220-24-000008.md","text":"https://secwatch.observer/filing/0001808220-24-000008.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1808220/000180822024000008/0001808220-24-000008-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1808220/000180822024000008/goco-20240314.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T21:28:42.977939+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b524c4856206046922d2fdee11a84b313bf7ba56","claim":"GoHealth, Inc. reported the fourth quarter and year ended December 31, 2023 results: revenue $276.7 million, net income net loss was $2.3 million.","evidence_excerpt":"Fourth quarter 2023 net revenues were $276.7 million, compared to $69.4 million in the prior year period. Full year 2023 net revenues were $734.7 million, compared to $631.7 million in 2022. • Fourth quarter 2023 net loss was $2.3 million and Adjusted EBITDA 1 was $57.0 million, improvements of 98.5% and 160.1%, respectively, compared to the prior year period. Full year 2023 net loss of $151.3 million and Adjusted EBITDA 1 of $75.1 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1808220/000180822024000008/0001808220-24-000008-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter and year ended December 31, 2023"},{"label":"Revenue","value":"$276.7 million"},{"label":"Net income","value":"net loss was $2.3 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}